Literature DB >> 14718618

Evolutionary study of HVR1 of E2 in chronic hepatitis C virus infection.

Victoria Alfonso1, Diego Martín Flichman1, Silvia Sookoian2, Viviana Andrea Mbayed1, Rodolfo Héctor Campos1.   

Abstract

Hypervariable region 1 (HVR1) of the hepatitis C virus (HCV) genome was directly sequenced from 12 chronically infected patients who had not responded to interferon (IFN) treatment. Due to the quasispecies nature of HCV circulating genomes, serum samples from four patients showing different evolutionary characteristics were further analysed. Serial samples from each patient were taken before, soon after and 14-23 months after a 6 month IFN treatment. HVR1 from each sample was amplified, cloned and the clones sequenced. For each patient, a phylogenetic analysis of the clones was performed and quasispecies complexity and genetic distances were calculated. The amino acid sequences and predicted antigenic profiles were analysed. The pre-treatment samples of the different patients presented dissimilar genetic quasispecies composition. For three of the patients, we showed that, regardless of the complexity or diversity of the viral populations before treatment, they evolved towards genetic diversification following selective pressure. Once the environment became stable, the entire population tended towards homogeneity. The fourth patient represented a case where different components of the quasispecies coexisted for long periods without replacement. We propose herein that the evolution of HVR1 of E2 is more likely to be directed by selection of clearly different subpopulations (modification of quasispecies equilibrium) than by a continuous mechanism related to the successive accumulation of point mutations. The prevalence of a quasispecies shift mechanism was revealed by the cloning analysis during the follow-up period of the evolutionary process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718618     DOI: 10.1099/vir.0.19403-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  Plasma and liver hepatitis C virus variability in patients coinfected with human immunodeficiency virus.

Authors:  Anne-Christine Jouvencel; Didier Neau; Muriel Faure; Martine Neau; Christophe Martinaud; Elisabeth Legrand; Pascale Trimoulet; Isabelle Garrigue; Brigitte Le Bail; Paulette Bioulac-Sage; Michel Dupon; Jean-Marie Ragnaud; Herve Fleury; Marie-Edith Lafon
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

2.  Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C.

Authors:  Hui Li; Brian J McMahon; Susan McArdle; Dana Bruden; Daniel G Sullivan; Dave Shelton; Heike Deubner; David R Gretch
Journal:  Virology       Date:  2008-03-17       Impact factor: 3.616

3.  Characterization of hepatitis C Virus genotype 3a hypervariable region 1 in patients achieved rapid virological response to alpha interferon and ribavirin combination therapy.

Authors:  Madiha Akram; Muhammad Idrees; Abrar Hussain; Samia Afzal; Muhammad Ilyas; Shamail Zafar; Mahwish Aftab; Sadaf Badar; Bushra Khubaib
Journal:  Virol J       Date:  2011-05-23       Impact factor: 4.099

Review 4.  Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.

Authors:  Ahmed El-Shamy; Hak Hotta
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

5.  Adaptation to human populations is revealed by within-host polymorphisms in HIV-1 and hepatitis C virus.

Authors:  Art F Y Poon; Sergei L Kosakovsky Pond; Phil Bennett; Douglas D Richman; Andrew J Leigh Brown; Simon D W Frost
Journal:  PLoS Pathog       Date:  2007-03       Impact factor: 6.823

Review 6.  Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections.

Authors:  Cordelia Manickam; R Keith Reeves
Journal:  Front Microbiol       Date:  2014-12-08       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.